A cancer-specific anti-podocalyxin monoclonal antibody (60-mG<sub>2a</sub>-f) exerts antitumor effects in mouse xenograft models of pancreatic carcinoma.
第一作者:
Mika K,Kaneko
第一单位:
Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.
作者:
关键词
ADCC, antibody-dependent cellular cytotoxicityBSA, bovine serum albuminCBIS, Cell-Based Immunization and ScreeningCDC, complement-dependent cytotoxicityCancer-specific mAbCasMab, cancer-specific monoclonal antibodyMonoclonal antibodyPBS, phosphate-buffered salinePODXLPODXL, podocalyxinPancreatic cancerPodocalyxin
DOI
10.1016/j.bbrep.2020.100826
PMID
33088928
发布时间
2020-10-23
- 浏览0
Biochemistry and biophysics reports
2020年24卷
100826页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



